Colorectal cancer is a leading cause of cancer-related deaths in the United States, but new research suggests that improved communication about genetic risks within families could lead to earlier detection and better outcomes. The Alliance for Clinical Trials in Oncology has launched a new clinical study, “Family Communications After Genetic Testing,” to explore the most effective ways to share potentially life-saving information about inherited cancer risks.
The trial, supported by grants from the National Cancer Institute, will enroll approximately 4,000 colorectal cancer patients and their at-risk relatives across the U.S. It comes at a crucial time, coinciding with Colorectal Cancer Awareness Month in March, and addresses a significant gap in healthcare: many individuals are unaware of the familial link to this disease. Approximately 30% of colorectal cancer cases are linked to genetic factors, and around 15% of newly diagnosed patients carry a gene change – known as a pathogenic germline variant – that increases their risk.
Understanding these genetic connections is vital, as it allows close relatives – parents, children, and siblings – to proactively pursue earlier screening and preventative measures. However, a critical barrier exists: often, this crucial information doesn’t reach those who need it most. This new study aims to overcome that hurdle by testing different communication strategies.
Comparing Communication Approaches
The “Family Communications After Genetic Testing” trial will compare two distinct methods for sharing genetic test results with family members. The first approach, termed “proband-mediated communication,” involves the patient sharing the information directly with their relatives. The second, “provider-mediated communication,” entails a healthcare provider reaching out to family members to explain the findings and recommend genetic testing. Researchers hope to determine which method is more effective in encouraging at-risk relatives to undergo testing.
“Sharing genetic information can be stressful and confusing, especially right after a cancer diagnosis,” explained Frank Sinicrope, MD, study co-chair and a gastroenterologist at the Mayo Clinic in Rochester, Minnesota. “Some patients aren’t sure how to explain test results, whereas others worry about upsetting loved ones. This study hopes to identify a clear, helpful approach that makes it easier for families to understand their risks and seize preventive action.”
What Researchers Hope to Learn
The study has several key objectives. Researchers will track how many first-degree relatives complete genetic testing using each communication approach. They will likewise assess whether relatives who learn they carry a gene change take proactive steps to protect their health within 12 months, such as increased screening through colonoscopies or at-home testing kits. The study will investigate how these communication methods resonate with diverse populations, considering factors like age, ethnicity, and geographic location (rural versus urban).
The trial is open to individuals diagnosed with colorectal cancer, stages I to IV, within the past three months. Heather Hampel, M.S., CGC, study co-chair and a genetic researcher with the City of Hope cancer center in Duarte, California, emphasized the importance of early detection. “Our study aims to improve communication between patients and families about the genetic risks of cancer in the hopes of catching or preventing colorectal cancers early when they are most easily treated.”
The Alliance for Clinical Trials in Oncology is dedicated to reducing the impact of cancer through collaborative research. As a member of the National Cancer Institute’s National Clinical Trials Network, the Alliance plays a vital role in advancing cancer prevention and treatment strategies. You can learn more about their operate and other clinical trials on their website: Alliance for Clinical Trials in Oncology.
The findings from this study are expected to provide valuable insights into how best to support families navigating the complexities of inherited cancer risk. As the trial progresses, researchers will continue to analyze data and refine their understanding of effective communication strategies. The ultimate goal is to empower families with the knowledge they need to develop informed decisions about their health and potentially prevent future cases of colorectal cancer.
Share your thoughts and experiences in the comments below. If you found this information helpful, please share it with your network.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
